SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016809
Filing Date
2023-05-15
Accepted
2023-05-15 06:04:34
Documents
46
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 726685
2 ex31-1.htm EX-31.1 11464
3 ex31-2.htm EX-31.2 11292
4 ex32-1.htm EX-32.1 6722
5 ex32-2.htm EX-32.2 6786
  Complete submission text file 0001493152-23-016809.txt   3663607

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ladx-20230331.xsd EX-101.SCH 21621
7 XBRL CALCULATION FILE ladx-20230331_cal.xml EX-101.CAL 31516
8 XBRL DEFINITION FILE ladx-20230331_def.xml EX-101.DEF 110567
9 XBRL LABEL FILE ladx-20230331_lab.xml EX-101.LAB 225539
10 XBRL PRESENTATION FILE ladx-20230331_pre.xml EX-101.PRE 179614
40 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 528326
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
LadRx Corp (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15327 | Film No.: 23918095
SIC: 2836 Biological Products, (No Diagnostic Substances)